Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Alternative splicing–triggered mRNA decay informs splice-switching targets for neurodevelopmental disorders
Kaining Hu, Runwei Yang, Jiaming Qiu, Xinran Feng, Kayleigh J. LaPre, Jessica Tanouye, Yalan Yang, Xiaochang Zhang
Kaining Hu, Runwei Yang, Jiaming Qiu, Xinran Feng, Kayleigh J. LaPre, Jessica Tanouye, Yalan Yang, Xiaochang Zhang
View: Text | PDF
Research Article Development Neuroscience

Alternative splicing–triggered mRNA decay informs splice-switching targets for neurodevelopmental disorders

  • Text
  • PDF
Abstract

Alternative splicing–triggered nonsense-mediated mRNA decay (AS-NMD) critically regulates gene expression, but the extent to which neuronal genes are regulated by AS-NMD remains understudied. Here, we identified over 3,000 developmentally regulated AS-NMD exons in mouse and human brains and validated them in cultured neurons. AS-NMD suppresses synaptic genes during brain development and differentially regulates more than 200 causal genes for neurodevelopmental disorders (NDDs). We detected a poison exon in GRIA2 and identified splice-switching antisense oligonucleotides that suppressed GRIA2 NMD and increased its functional isoforms. In summary, this study uncovers genes repressed by AS-NMD in the brain and nominates amenable splice-switching targets for treating dominant NDDs such as autism spectrum disorders and developmental epileptic encephalopathy.

Authors

Kaining Hu, Runwei Yang, Jiaming Qiu, Xinran Feng, Kayleigh J. LaPre, Jessica Tanouye, Yalan Yang, Xiaochang Zhang

×

Figure 1

Identifying AS-NMD exons with EANMD.

Options: View larger image (or click on image) Download as PowerPoint
Identifying AS-NMD exons with EANMD.
(A) An outline of the EANMD pipelin...
(A) An outline of the EANMD pipeline. AS events are identified from long- or short-read data, followed by transcript-level NMD prediction. The XGBoost machine learning model is applied to classify NMD flags and assign NMD scores. (B) Experimental datasets used for AS-NMD validation, including (a) Neuro2a cells with Upf1 KD (n = 2 biological replicates), (b) primary mouse neurons treated with CHX (n = 2), and (c) Upf2 conditional knockout in embryonic mouse neocortex (n = 2) (Lin et al., ref. 20). (C) Violin plots showing ΔPSI (left) and log2FC in gene expression (right) for NMD versus non-NMD SE events upon Upf1 KD. Events triggering NMD exhibit increased transcript abundance after NMD inhibition, serving as a proxy for NMD efficiency. NMD_in (n = 43), NMD_ex (n = 63), ORF preserving (n = 90), and ORF changing (n = 4) events (1-way ANOVA followed by Tukey’s multiple-comparison test). (D) SHAP values of the minimum stop codon position fraction (Min stop Pos F) and the maximum stop codon distance to the last exon-exon junction (Max DJ), highlighting their interaction effect on NMD efficiency. (E) SHAP analysis of 3′-UTR length. NMD efficiency increased when 3′ UTRs were either longer than 1,150 nt or shorter than 180 nt. MFE, minimum free energy. (F) Receiver operating characteristic (ROC) curves for NMD classification. Using the 50 nt rule, the ROC-AUC is 0.680 (gray line). Incorporating the machine learning–predicted NMD score improves classification performance (AUC = 0.752, total SE events, navy blue line). ML, machine learning. (G) Filtering events based on NMD scores enhances AS-NMD detection.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts